ILARIS

canakinumab · Novartis Pharmaceuticals Corporation

Drug timelines are a Plus or Pro feature.

37 regulatory and trial events tracked for ILARIS, covering 2009-06-17 to 2026-04-08. Get the full timeline:

Most recent: Clinical Trial Update: A Study on the Use of Canakinumab Among Familial Mediterranean Fever and Still's Disease Patients